EPALRESTAT Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description A monocarboxylic acid that is 1,3-thiazolidine which is substituted on the nitrogen by a carboxymethyl group, at positions 2 and 4 by thioxo and oxo groups, respectively, and at position 5 by a 2-methyl-3-phenylprop-2-en-1-ylidene group. It is an inhibitor of aldose reductase (which catalyses the conversion of glucose to sorbitol) and is used for the treatment of some diabetic complications, including neuropathy. (Chemical Entities of Biological Interest Ontology, CHEBI_31539)
External Link https://dgidb.org/results?searchType=drug&searchTerms=EPALRESTAT
Similar Terms
Downloads & Tools

Genes

5 interacting proteins for the EPALRESTAT drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
CYP4A11 cytochrome P450, family 4, subfamily A, polypeptide 11 3.5288
AKR1B1 aldo-keto reductase family 1, member B1 (aldose reductase) 1.11436
SLC5A7 solute carrier family 5 (sodium/choline cotransporter), member 7 0.341497
MAPT microtubule-associated protein tau 0.0238432
VDR vitamin D (1,25- dihydroxyvitamin D3) receptor 0.0216934